alexa mTOR Silencing in Parkinson's Disease

OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

mTOR Silencing in Parkinson's Disease

Mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates processes including mRNA translation, proliferation, and survival. As a central element signaling cell growth and enhancing protein translation, (mTOR), when inhibited, induces autophagy. Moreover, as a critical feedback mechanism, reactivation of mTOR terminates autophagy and initiates lysosome reformation.

Citation: Salama M (2015) mTOR Silencing in Parkinson's Disease both in vitro and in vivo. Brain Disord Ther 4:167.

  • Share this page
  • Facebook
  • Twitter
  • LinkedIn
  • Google+
  • Pinterest
  • Blogger